MetLife Investment Management, LLC

Position in DNA — Ginkgo Bioworks Holdings, Inc.

CIK 1529735 Whippany, NJ

Position in DNA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$285,110

+$144,439 QoQ

Shares Held

28,770

+25.4% QoQ

Ownership

0.043%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#77

of 183 holders

Holding Since

Jun 2022

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $430,307,229 across 249 Biotechnology names. DNA ranks #166 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc.	402,605	$31,511,893
2	PRAX	Praxis Precision Medicines, Inc.	90,543	$30,312,890
3	VRTX	Vertex Pharmaceuticals Inc / Ma	58,072	$28,846,104
4	FTRE	Fortrea Holdings Inc.	1,362,169	$23,701,740
5	AXSM	Axsome Therapeutics, Inc.	89,662	$21,946,567
6	IMNM	Immunome Inc.	859,076	$18,203,820
7	REGN	Regeneron Pharmaceuticals, Inc.	22,880	$14,266,595
8	CYTK	Cytokinetics Inc	140,046	$11,930,518

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$285,110	28,770	+25.4%	Shares	Defined	2026-08-14
2026-03-31	$140,671	22,948	+24.3%	Shares	Defined	2026-05-14
2025-12-31	$153,477	18,469	-23.8%	Shares	Defined	2026-02-12
2025-09-30	$353,521	24,247	0.0%	Shares	Defined	2025-11-13
2025-06-30	$272,778	24,247	-33.7%	Shares	Defined	2025-08-13
2024-03-31	$42,452	36,597	+1.4%	Shares	Defined	2024-05-14
2023-12-31	$60,990	36,089	-0.5%	Shares	Defined	2024-04-22
2023-09-30	$65,632	36,261	+0.1%	Shares	Defined	2024-05-09
2023-06-30	$67,365	36,218	+46.6%	Shares	Defined	2024-04-29
2023-03-31	$32,853	24,702	+0.2%	Shares	Defined	2024-05-09
2022-12-31	$41,653	24,647	+3.8%	Shares	Defined	2024-05-10
2022-09-30	$74,109	23,753	-1.3%	Shares	Defined	2024-05-10
2022-06-30	$57,291	24,072	—	Shares	Defined	2024-05-10
No filing history on record for this holder in this stock.